| Literature DB >> 28011064 |
Sion K Harris1, Matthew C Aalsma2, Elissa R Weitzman1, Diego Garcia-Huidobro3, Charlene Wong4, Scott E Hadland1, John Santelli5, M Jane Park6, Elizabeth M Ozer7.
Abstract
We reviewed research regarding system- and visit-level strategies to enhance clinical preventive service delivery and quality for adolescents and young adults. Despite professional consensus on recommended services for adolescents, a strong evidence base for services for young adults, and improved financial access to services with the Affordable Care Act's provisions, receipt of preventive services remains suboptimal. Further research that builds off successful models of linking traditional and community clinics is needed to improve access to care for all youth. To optimize the clinical encounter, promising clinician-focused strategies to improve delivery of preventive services include screening and decision support tools, particularly when integrated into electronic medical record systems and supported by training and feedback. Although results have been mixed, interventions have moved beyond increasing service delivery to demonstrating behavior change. Research on emerging technology-such as gaming platforms, mobile phone applications, and wearable devices-suggests opportunities to expand clinicians' reach; however, existing research is based on limited clinical settings and populations. Improved monitoring systems and further research are needed to examine preventive services facilitators and ensure that interventions are effective across the range of clinical settings where youth receive preventive care, across multiple populations, including young adults, and for more vulnerable populations with less access to quality care.Entities:
Keywords: Adolescents; Preventive services; Young adults
Mesh:
Year: 2016 PMID: 28011064 PMCID: PMC5549464 DOI: 10.1016/j.jadohealth.2016.10.005
Source DB: PubMed Journal: J Adolesc Health ISSN: 1054-139X Impact factor: 5.012
Figure 1The framework emphasizes the crucial importance of a life course perspective in the understanding of adolescent health and development (represented by the horizontal flow of the framework) and the importance of social determinants of health (vertical flow). The axes intersect around the unique characteristics of adolescence (the complex interactions between puberty, neurocognitive maturity, and social role transitions) to emphasize how these factors affect adolescent health and development. The text outside the boxes refers to settings and scope of policies, preventive interventions, and services that affect adolescent health. From Sawyer SM, Afifi RA, Bearinger LH, et al. Adolescence: A foundation for future health. Lancet 2012;379:1630–40.
Services covered by the Affordable Care Act, by guideline source
| Measure | USPSTF <18 | USPSTF ≥18 | Bright futures | HRSA Women’s Guidelines |
|---|---|---|---|---|
| Nutrition/exercise/obesity | ||||
| Obesity/body mass index | ✓>6 y | ✓All adults | ✓ | ✓All adults and children |
| Hypertension/blood pressure | — | ✓≥18 y | ✓ | “Covered in child well visit” |
| Lipid disorder | — | ✓≥20 y and risk factors | ✓In late adolescence | ✓Children and adults with risk factors |
| Healthy diet | — | ✓Adults with risk factors | ✓ | ✓Adults with risk factors |
| Routine counseling for physical activity | — | — | ✓ | — |
| Substance use | ||||
| Tobacco use | ✓School-aged children and adolescents | ✓Adults, including pregnant women who use tobacco >18 | After risk assessment | ✓All adults and cessation interventions for tobacco users |
| Alcohol use | NR | ✓All adults | After risk assessment | ✓Adults and adolescents |
| Mental health | ||||
| Suicide screening | NR | NR | ✓ | — |
| Screening for depression | ✓12–18 y, screening for major depressive disorder should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. | ✓Adults, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. | ✓ | ✓Adults and adolescents |
| Other illicit drug use (screening and counseling) | NR | NR | After risk assessment | — |
| Safety/violence | ||||
| Family/partner violence | ✓Women of childbearing age | ✓Women of childbearing age | ✓ | ✓All women |
| Fighting | — | — | ✓ | — |
| Helmets | — | — | ✓ | — |
| Seat belts | — | — | ✓ | — |
| Guns | — | — | ✓ | — |
| Bullying | — | — | ✓ | — |
| Reproductive health | ||||
| STI screening | ✓Sexually active adolescents and adults at increased risk | ✓Sexually active adolescents and adults at increased risk | ✓If sexually active | ✓Adults and adolescents with risk factors |
| STI counseling | ✓Sexually active adolescents and adults at increased risk | ✓Sexually active adolescents and adults at increased risk | ✓If sexually active | ✓Adults and adolescents with risk factors |
| Cervical cancer screening | — | ✓≥21, every 3 years | ✓If sexually active within 3 years of onset of sexual activity or no later than age 21 | ✓Sexually active women |
| Chlamydia screening (female) | ✓Sexually active ≤24 y | ✓Sexually active ≤24 y | ✓If sexually active | ✓Younger women and other women with risk factors |
| Chlamydia screening (male) | NR | NR | Screen in sexually active adolescents | — |
| Gonorrhea screening | ✓Sexually active ≤24 y | ✓Sexually active ≤24 y | ✓If sexually active | ✓Women at increased risk |
| HIV screening | ✓Adolescents and adults (16–65 y) at increased risk for HIV infection | ✓Adolescents and adults (16–65 y) at increased risk for HIV infection | ✓If sexually active and + on risk assessment | ✓Anyone 15 to 65 y at least once |
| Syphilis screening | ✓All persons at increased risk for syphilis infection | ✓All persons at increased risk for syphilis infection | ✓If sexually active and + on risk assessment | ✓Women at increased risk |
| Pregnancy | — | — | ✓Sexually active females w/o contraception, late menses, amenorrhea, or heavy or irregular bleeding | — |
| Birth control methods | — | — | ✓ | Most insurance plans must cover birth control that is prescribed by a woman’s doctor |
| Screening | ||||
| Testicular cancer | Recommended against | Recommended against | ✓In late adolescence | — |
| Anemia test | — | — | After risk assessment | ✓Routinely for pregnant women |
| Tuberculosis test | Update in progress | Update in progress | After risk assessment | ✓Children at high risk of tuberculosis |
| Hearing test: audiometry | — | — | After risk assessment | — |
| Vision test: Snellen test | — | — | ✓ln each stage of adolescence | ✓Children of all ages |
|
| ||||
| Immunizations As Recommended By the CDC | 11–12 | 13–18 | 19–26 | |
|
| ||||
| Tetanus, diphtheria, pertussis (Tdap/TD) | * | Catch up | Substitute one-time dose of Tdap for Td booster; then boost with Td every 10 y | |
| Human papillomavirus | *** | Catch up | ***For males if risk factor present or as catch up. ***For females as catch up only | |
| MCV4 (Meningococcal) | * | Booster at age 16 or catch up | *Or more if risk factor is present | |
| HepB (Hepatitis B) | Catch up | Catch up | ***If risk factor is present | |
| Polio | Catch up | Catch up | ***If at increased risk of exposure to poliovirus or who have never been vaccinated against polio | |
| MMR (measles, mumps, rubella) | Catch up | Catch up | * Or **doses if risk factor present or as catch up | |
| Varicella (chickenpox) | Catch up | Catch up | **If risk factor is present | |
| Hepatitis A | Catch up | Catch up | **If risk factor is present | |
| Pneumococcal (polysaccharide) | For those meeting CDC’s risk criteria | For those meeting CDC’s risk criteria | For those meeting CDC’s risk criteria | |
| Influenza | Recommended annually | Recommended annually | Recommended annually | |
*, **, *** denote number of doses.
NR = insufficient evidence to recommend for or against; Recommend Against = recommend against; USPSTF = U.S. Preventive Services Task Force; y = years; ✓ = a recommendation; – = No mention of recommendation.
Adapted from Centers for Disease Control and Prevention. 2015 Recommended Immunizations for Children from 7 through 18 years old. http://www.cdc.gov/vaccines/who/teens/downloads/parent-version-schedule-7-18yrs.pdf.
Summary of recommendations for future research in adolescent and young adult clinical preventive services
Examine clinical preventive services delivery and effectiveness among young adults as a population distinct from adolescents and other adults. Apply advances in developmental science (including understanding of key developmental windows for optimal service effectiveness) to improve models of care and brief interventions for adolescents, young adults, and parents. Clarify the role of the health care system, and of parents, in supporting healthy developmental transitions for adolescents and young adults. Improve monitoring and tracking of the delivery of clinical preventive services, including:
Develop standardized measures Urge federal agencies responsible for public health monitoring systems to align data collection with preventive services recommended in the Affordable Care Act, particularly those that are evidence-based. Identify continuously collected data sources, including EMRs, that can be leveraged to inform clinical preventive services for adolescent and young adult health promotion. |
Examine the extended effects of shifts in health insurance policy (e.g., the Affordable Care Act) on adolescent and young adult clinical preventive services access, utilization, and health outcomes. Respond to shifts in the healthcare system and service delivery contexts (e.g., vaccinations and other preventive health offered outside clinic offices) to inform the development of a more nimble clinical model and innovative preventive care strategies. Examine strategies to reduce disparities, particularly promoting linkages between traditional health care facilities and adolescents and young adults (AYA)–serving community-based agencies such as schools, juvenile justice settings, and community-based youth services organizations. |
| Clinician-targeted strategies
Implement and evaluate larger, practice-based, multisite research trials of promising clinician-focused interventions such as those that incorporate training and screening tools and clinical decision support systems in electronic medical record systems. Continue to evaluate the effects and potential of electronic medical record systems to improve preventive services delivery and quality in pediatric health settings. |
| Parent engagement |
| Implement developmentally and culturally appropriate strategies to engage parents in the clinical encounters of AYAs and evaluate their effects on the receipt of clinical preventive services and health outcomes. |
| Improving AYA behavior/health: efficacy of clinical preventive interventions
Prioritize more rigorous, outcomes-focused research that studies the effect of AYA-targeted clinical preventive services on behavior change or health outcomes, both short and long term. Implement and evaluate the interventions’ effectiveness in different settings and on a broader scale. Identify effective, brief, practical generalized (i.e., nonsilo) interventions within developmental windows of opportunities. Deepen our understanding of behavior change interventions, including the framing and timing of health information and messages, and what components are most effective. Develop criteria for publishing/reporting on intervention outcomes and how evidence-based principles are applied (e.g., what are the intervention’s “active ingredients” and mechanisms of action). |
| Using technology to extend clinicians’ preventive reach |
| Leverage new technological tools (e.g., computer programs, mobile devices, wearable sensors) to enhance/improve AYA health services Develop interventions that provide adolescents/young adults with guidance in navigating complex systems that are providing health information and develop and health and media safety literacy (e.g., online sites, social networks, etc.) Prioritize rigorous and timely outcomes-focused research on use of “clinician extenders” Identify safety and quality criteria for health technology platforms with a focus on youth needs. |